Bioanalytical Testing

Maxxam has experience providing bioanalytical support and API characterization of platinum based therapeutics such as cisplatin, carboplatin and oxaliplatin. The laboratory utilizes conventional and chromatography coupled Inductively Coupled Mass Spectrometry (ICPMS) to provide superior sensitivity and specificity.

With the application of chromatography coupled techniques, scientists can make direct measurement of free, DNA/protein bound and equilibrium species.

The laboratory has handled drug compounds containing precious metals, rare earths, bismuth, transition metals and others. Maxxam has established validated methods for metallo-drug assays using inductively coupled plasma mass spectrometry (ICP-MS) at the low to sub ng/mL levels in common matrices of clinical interest, including urine, plasma and plasma ultrafiltrate.

The laboratory has handled drug compounds containing precious metals, rare earths, bismuth, transition metals and others. Maxxam has established validated methods for metallo-drug assays using inductively coupled plasma mass spectrometry (ICP-MS) at the low to sub ng/mL levels in common matrices of clinical interest, including urine, plasma and plasma ultrafiltrate. Maxxam also has many pre-validated “off the shelf” bioanalytical methods available for other oncology drugs such as azathioprine and 6-mercaptopurine.

By

Donna Garbutt, M.B.A. Chief Executive Officer Maxxam is the Canadian market leader in analytical services and solutions to the energy, environmental, food and DNA industries and a member of the Bureau Veritas Group of companies – a world leader in testing, inspection and certification services. We support critical decisions made by our customers through the application of rigorous science and the knowledge and expertise of our over 2200 employees. Our annual Corporate Responsibility Report outlines our efforts to continually improve our business performance and practices. Its publication is an industry first and an integral part of our commitment to success with responsibility. LinkedIn
Maxxam Analytics Maxxam is the Canadian market leader in analytical services and solutions to the energy, environmental, food and DNA industries and a member of the Bureau Veritas Group of companies – a world leader in testing, inspection and certification services. We support critical decisions made by our customers through the application of rigorous science and the knowledge and expertise of our over 2200 employees. Our annual Corporate Responsibility Report outlines our efforts to continually improve our business performance and practices. Its publication is an industry first and an integral part of our commitment to success with responsibility.
500 – 1919 Minnesota Ct., Mississauga, Ontario L5N 0C9
Phone: (905) 288-2150